Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Comment by gonchpullon Apr 28, 2011 5:13pm
317 Views
Post# 18503194

RE: RE: RE: Curveball. GPRO seeking a buyer.

RE: RE: RE: Curveball. GPRO seeking a buyer.well maybe morgan stanley will advise them to buy out cur and get rid of this royalty before they sell gpro. do you think novartis would be excitied about paying cur 17% of pca3 revenues?  someone will make a move on cur.  this stock is definately drifting lower as cibc and nb keep dropping small amounts of shares into the market.
Bullboard Posts